Addressing COVID-19 Health Disparities Act
Do you support it?
Want to know if it passes?
We'll email you when HR 8067 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 8067.
You're tracking HR 8067
We'll email you the moment it moves.
HR 8067 — Addressing COVID-19 Health Disparities Act
Last action — Referred to the House Committee on Energy and Commerce.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
Died in session
This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Requires the Agency for Healthcare Research and Quality (AHRQ) to research the U.S. health care system's response to COVID-19 (i.e., coronavirus disease 2019), including by identifying health care-related factors that contribute to racial and ethnic disparities in COVID-19 outcomes and strategies to mitigate those factors. In addition, AHRQ must develop vaccine protocols and strategies in consultation with leaders from populations disproportionately affected by COVID-19 to ensure that such groups have timely access to vaccines.
Bill Text
We don't have the full text on file for this bill yet.
Read HR 8067 on the official United States source →Action History
-
Referred to the House Committee on Energy and Commerce.
-
Introduced in House
Sponsors
- Don Beyer · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 8067 do?
- Requires the Agency for Healthcare Research and Quality (AHRQ) to research the U.S. health care system's response to COVID-19 (i.e., coronavirus disease 2019), including by identifying health care-related factors that contribute to racial and ethnic disparities in COVID-19 outcomes and strategies to mitigate those factors. In addition, AHRQ must develop vaccine protocols and strategies in consultation with leaders from populations disproportionately affected by COVID-19 to ensure that such groups have timely access to vaccines.
- Who sponsors HR 8067?
- HR 8067 is sponsored by Don Beyer (D).
- What is the current status of HR 8067?
- This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 8067?
- Track HR 8067 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 8067
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 8067
Last checked for changes about 10 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →